Main CBER makes presentations at public meetings to facilitate biologics development on medical countermeasures (MCM) against the effects of chemical, biological, radiological, and nuclear (CBRN) agents. This measure is the number of external presentations by CBER staff at meetings sponsored by professional societies, consortia, academia, or other government entities in that quarter. The CBER program measures will be reported on a quarterly basis with the data shown on the third month of the quarter. There are no fiscal year targets established. column

FY 2011 3 Month Total: 8

Oct - Dec 2010 N/A Jan - Mar 2011 N/A Apr - Jun 2011 N/A Jul - Sep 2011 8

FY 2012 Total: 154

Oct - Dec 2011 23 Jan - Mar 2012 20 Apr - Jun 2012 68 Jul - Sep 2012 43

Oct-Dec 2012 26 Jan–Mar 2013 Apr–Jun 2013 Jul-Sept 2013 http://www.fda.gov/AboutFDA/Transparency/track/ucm237964.htm FDA-TRACK Medical Countermeasures Initiative (MCMi) Dashboard http://www.fda.gov/EmergencyPreparedness/MedicalCountermeasures/default.htm Medical Countermeasures Initiative (MCMi) ਍††਍਍਍਍਍਍਍